Ulnar Nerve Block for Procedural Anesthesia - Wrist Versus Palm

Sponsor
Hamilton Health Sciences Corporation (Other)
Overall Status
Terminated
CT.gov ID
NCT00827658
Collaborator
McMaster University (Other)
127
1
2
17
7.5

Study Details

Study Description

Brief Summary

Ulnar nerve blockade is necessary for sensory anesthesia and analgesia in the hand during minor procedures. The course of the ulnar nerve in the forearm, wrist, and hand is predictable and has low variability. However even with known anatomic location and landmarks, ulnar nerve blocks at the wrist frequently are inadequate for procedural anesthesia. The antebrachial fascia at the wrist acts as a barrier to local infiltration. Since the fascia can not be visualized or palpated, it is commonly not penetrated, resulting in an inadequate block. Furthermore at the level of the wrist the ulnar artery lies in close proximity to the nerve and there is potential for arterial puncture while attempting injection for volar wrist block. The palmar ulnar nerve block is an injection distal to the hook of the hamate in the thenar eminence which avoids the ulnar artery and antebrachial fascia. This block has been used successfully for many years in clinical practice but has not been assessed or compared in a research study. The purpose of this study is to assess the validity of using a palmar ulnar nerve block for procedures in the hand as compared to the standard volar wrist ulnar nerve block.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Volar Wrist Block
  • Procedure: Hypothenar Palm block
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
127 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Ulnar Nerve Block for Procedural Anesthesia - Wrist Versus Palm
Study Start Date :
Feb 1, 2008
Actual Primary Completion Date :
Jul 1, 2009
Actual Study Completion Date :
Jul 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Hypothenar Palm block

Hypothenar Palmar block group. Local anesthetic is placed at this location in this study group. The same local composition (Intervention) is used for both study groups. The trial is a comparison of location not the Intervention.

Procedure: Hypothenar Palm block
Injection at Hook of the Hamate on Palmar surface Local Block - total 3 cc injection (1.5 cc 1% plain lidocaine and 1.5 cc of 0.25% bupivicaine)

Active Comparator: Volar Wrist Block

Volar Wrist block group. Local anesthetic is placed at this location in this study group. The same local composition (Intervention) is used for both study groups. The trial is a comparison of location not the Intervention.

Procedure: Volar Wrist Block
Injection medial to Flexor Carpi Ulnaris Tendon at volar proximal wrist crease Local Block - total 3 cc injection (1.5 cc 1% plain lidocaine and 1.5 cc of 0.25% bupivicaine)

Outcome Measures

Primary Outcome Measures

  1. Primary outcome is efficacy of sensory anesthesia and analgesia [15-45 minutes]

Secondary Outcome Measures

  1. Secondary outcome is patient perceived discomfort with block [15-45 Minutes]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • any individual who can give informed consent and is scheduled for elective hand procedures by the PI necessitating an Ulnar nerve block of the hand.
Exclusion Criteria:
  • patients unable to give informed consent

  • patients with previous or ongoing ulnar nerve deficits or neuropathy

  • patients undergoing Guyon's canal decompression

  • patients who can not comprehend or cooperate with assessment testing

  • patients with abnormal two point discrimination (> 6 mm at the test location) prior to the nerve block

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hamilton General Hospital Hamilton Ontario Canada

Sponsors and Collaborators

  • Hamilton Health Sciences Corporation
  • McMaster University

Investigators

  • Principal Investigator: Stuart Martin, McMaster University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hamilton Health Sciences Corporation
ClinicalTrials.gov Identifier:
NCT00827658
Other Study ID Numbers:
  • McMaster 08-053
First Posted:
Jan 23, 2009
Last Update Posted:
May 14, 2018
Last Verified:
May 1, 2018

Study Results

No Results Posted as of May 14, 2018